Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
Edition
European
US
Respiratory
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
SARS-CoV-2 RNA Detection in Cough Droplets
November 2025
Device-captured cough droplets detected SARS-CoV-2 RNA and inflammatory biomarkers from the lower respiratory tract in patients.
Read more
22 Oct 2025
CHEST 2025: Ensifentrine Boosts Quality of Life in COPD
Ensifentrine improved symptoms, dyspnea, and quality of life in stable COPD without exacerbations in ENHANCE trials.
21 Oct 2025
CHEST 2025: New Algorithm Enhances AATD Diagnosis Accuracy
Alpha-1 antitrypsin deficiency (AATD) remains a frequently underdiagnosed condition that predisposes individuals to chronic lung and liver diseases.
21 Oct 2025
Osimertinib Plus Chemo Extends Survival in EGFR-Mutated NSCLC
Osimertinib plus chemotherapy improved overall survival versus monotherapy in EGFR-mutated advanced NSCLC in a Phase III trial.
20 Oct 2025
CHEST 2025: Nerandomilast Shows Promise in Slowing IPF Decline
In a Phase III trial, the addition of nerandomilast demonstrated a promising ability to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF).
18 Oct 2025
Nirsevimab Lowers RSV Hospitalization in US Infants
Nirsevimab administration was linked to lower RSV hospitalization among U.S. infants this season in analysis of real-world data.
16 Oct 2025
Azelastine Nasal Spray Shows Preventive Benefit
Azelastine nasal spray reduced PCR-confirmed SARS-CoV-2 infections versus placebo in a Phase II randomized trial in adults.
14 Oct 2025
Distinguishing
Mycoplasma pneumoniae
in Community-Acquired Pneumonia
Mycoplasma pneumoniae accounts for a meaningful share of community-acquired pneumonia in younger hospitalized adults.
11 Oct 2025
Early Body Size Signals Future COPD Risk
Childhood body size is linked to COPD risk in adulthood, with above-average BMI trajectories associated with higher COPD incidence.
Loading posts...
« Previous
1
2
3
4
…
24
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View